LD-2 disclosure · 1st Quarter - Report
UAB HEALTH SYSTEM
Client
- Description
- Academic Medical Center, School of Medicine and Public Health
- Government entity
- true
- Location
- Alabama · United States of America
Registrant
- Description
- Government Relations Consultant
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
5 issuesMedical/Disease Research/Clinical Labs
Department of Defense, Neurofibromatosis Biomedical research related issues Monitor the following: National Institutes of Health, Chronic Disease related issues National Institutes of Health, and various institutes and bureaus thereof CDC, generally
LobbyistsCHAD SCHULKEN · RAY COLE · GRAHAM HALL
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Hospital at Home Program, Entirety Graduate Medical Education (GME) Medicare Wage Index Disproportionate Share Hospital (DSH) Payments 340B issues Alabama Area Health Education Centers (AHEC) Agency for Healthcare Research and Quality related issues IDeA program related issues Medicare Reimbursement related issues Monitor the following: Medicaid Provider Hold Harmless Arrangements Medicare Sequestration Low Volume Hospitals and Medicare Dependent Hospitals Pay Go Medicare Cuts The Hospital Inpatient Payment Systems for Accute Care Hospitals and Long Term care Hospital Prospective Payment System (IPPS), Proposed Rule changes CMS Hospital Payment, Provider relief issues Provider and insurer rate negotiation ACA expansion issues
LobbyistsCHAD SCHULKEN · RAY COLE · GRAHAM HALL
TargetedSENATE · HOUSE OF REPRESENTATIVES
Budget/Appropriations
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2024, Higher education and training initiatives; Medical research and development; CDC/public health; NIH funding; IDEA program; Organ allocation issues; and Regional Biocontainment Laboratories Hospital and Graduate Medical Education related issues Implementation of Public Law 117-328, Consolidated Appropriations Act, FY2023, Higher education and training initiatives; Medical research and development; CDC/public health; NIH funding; IDEA program; Organ allocation issues; and Regional Biocontainment Laboratories
